Dr. Vicky Pratt, past president of AMP, and Prof. Dr. Ron van Schaik, past president of ESPT, have been at the forefront of the changing landscape of pharmacogenomic testing. There is increased notoriety and visibility to the importance of DPYD in treatment decisions. Now, more than ever, it is imperative to understand the significance of DPYD testing in the clinical setting. In this AMP 2023 workshop, both experts discuss the clinical evidence, recommendations and considerations supporting DPYD testing within the United States and Europe. Gain insights into evidence-based guidelines and other resources to consider when implementing DPYD testing panels.
Victoria M. Pratt, Ph.D., FACMG
Director, Scientific Affairs for Pharmacogenetics, Agena Bioscience
Prof. Dr. Ron HN van Schaik
IFCC Expert-Center Pharmacogenetics, Department of Clinical Chemistry, Erasmus University Medical Center
Recorded on November 15, 2023.
Learn more about our PGx Testing solutions.